U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.2724_2725delinsCA (p.Glu908_Leu909delinsAspIle) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Dec 6, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004517314.1

Allele description [Variation Report for NM_000059.4(BRCA2):c.2724_2725delinsCA (p.Glu908_Leu909delinsAspIle)]

NM_000059.4(BRCA2):c.2724_2725delinsCA (p.Glu908_Leu909delinsAspIle)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.2724_2725delinsCA (p.Glu908_Leu909delinsAspIle)
HGVS:
  • NC_000013.11:g.32337079_32337080delinsCA
  • NG_012772.3:g.26600_26601delinsCA
  • NM_000059.4:c.2724_2725delinsCAMANE SELECT
  • NM_001406719.1:c.2724_2725delinsCA
  • NM_001406720.1:c.2724_2725delinsCA
  • NM_001406721.1:c.1909+3692_1909+3693delinsCA
  • NM_001406722.1:c.424+6049_424+6050delinsCA
  • NP_000050.2:p.Glu908_Leu909delinsAspIle
  • NP_000050.3:p.Glu908_Leu909delinsAspIle
  • NP_001393648.1:p.Glu908_Leu909delinsAspIle
  • NP_001393649.1:p.Glu908_Leu909delinsAspIle
  • LRG_293t1:c.2724_2725delACinsCA
  • LRG_293:g.26600_26601delinsCA
  • LRG_293p1:p.Glu908_Leu909delinsAspIle
  • NC_000013.10:g.32911216_32911217delinsCA
  • NM_000059.3:c.2724_2725delACinsCA
  • NR_176251.1:n.2923_2924delinsCA
Molecular consequence:
  • NM_001406721.1:c.1909+3692_1909+3693delinsCA - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001406722.1:c.424+6049_424+6050delinsCA - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000059.4:c.2724_2725delinsCA - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406719.1:c.2724_2725delinsCA - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406720.1:c.2724_2725delinsCA - missense variant - [Sequence Ontology: SO:0001583]
  • NR_176251.1:n.2923_2924delinsCA - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005025645Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Dec 6, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV005025645.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.2724_2725delACinsCA variant (also known as p.E908_L909delinsDI), located in coding exon 10 of the BRCA2 gene, results from an in-frame deletion of AC and insertion of CA at nucleotide positions 2724 to 2725. This results in the substitution of glutamate and leucine residues for a aspartate and isoleucine residue at codon 908 and 909. This amino acid region is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 1, 2024